Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Fatty Liver a Possible Risk for Hypertension


The accumulation of fat in the liver, or "fatty liver," resulting from accumulation of central body fat, and perhaps not alcohol consumption, may represent an important underlying mechanism for the association between liver enzymes and hypertension.

The study, conducted by researchers at the University at Buffalo, appears in the current issue (November 2005) of the journal Hypertension.

"Our findings extend previous work, and indicate that the association of the liver enzyme GGT with hypertension risk is strongly affected by variation in weight and, above all, body fat distribution," said lead author Saverio Stranges, Ph.D., assistant professor of social and preventive medicine in the UB School of Public Health and Health Professions.

"Specifically, we found that GGT was a significant predictor of hypertension only among overweight participants with increased central body fat.

"If we consider that fatty liver is the most common cause of liver injury in the United States, these findings may have both important clinical and public health implications," said Stranges.

Alcohol consumption initially was thought to be the link between liver enzymes and high blood pressure for several reasons: Alcoholism is a known risk factor for hypertension; the liver enzyme GGT is a marker for alcohol consumption, and GGT also has been associated with hypertension.

In addition, chronic liver disease, in which GGT levels can be increased, often is associated with heavy alcohol consumption or actual alcoholism.

However, this study showed that the accumulation of fat in the liver, or "fatty liver" (in this case non-alcoholic fatty liver) in study participants with increased central body fat may be the important underlying mechanism linking GGT and hypertension. The association was found in nondrinkers as well as drinkers.

The study involved 1,455 participants who took part in the Western New York Health Study. A number of measures were taken at baseline, including GGT, blood pressure, weight, abdominal height and size of waistline.

At the six-year follow-up, participants were divided into five groups according to their baseline GGT levels. The baseline measurements were repeated, and participants completed questionnaires concerning lifestyle and health habits, including alcohol use.

Fatty liver has no symptoms, but it can develop into the chronic conditions of hepatitis or cirrhosis.

Stranges said these findings suggest that fatty liver should be considered part of the metabolic syndrome, a cluster of conditions physicians use to help assess a patient’s risk for cardiovascular disease.

Persons with any three of the conditions are considered at high risk. Conditions currently included in the metabolic syndrome are abdominal obesity, low HDL cholesterol, high blood sugar, high blood pressure and high triglycerides.

Stranges and colleagues are now studying the association between liver enzymes and diabetes.

Additional contributors to the research were Maurizio Trevisan, M.D., professor and dean of the School of Public Health and Professions, along with Joan M. Dorn, Ph.D., Jacek Dmochowski, Ph.D., and Richard Donahue, Ph.D., all of the UB Department of Social and Preventive Medicine.

The study was supported in part by a grant to Donahue from the National Institutes of Health.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York.

Lois Baker | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Oasis of life in the ice-covered central Arctic

24.10.2016 | Earth Sciences

‘Farming’ bacteria to boost growth in the oceans

24.10.2016 | Life Sciences

Light-driven atomic rotations excite magnetic waves

24.10.2016 | Physics and Astronomy

More VideoLinks >>>